Quipt Home Medical (NASDAQ:QIPT – Get Free Report) and Global Cord Blood (NYSE:CO – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations.
Profitability
This table compares Quipt Home Medical and Global Cord Blood’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Quipt Home Medical | -2.66% | -6.18% | -2.73% |
| Global Cord Blood | N/A | N/A | N/A |
Earnings & Valuation
This table compares Quipt Home Medical and Global Cord Blood”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Quipt Home Medical | $245.91 million | 0.53 | -$6.76 million | ($0.15) | -20.13 |
| Global Cord Blood | $1.24 billion | 0.10 | $79.04 million | $0.64 | 1.58 |
Analyst Ratings
This is a breakdown of recent recommendations for Quipt Home Medical and Global Cord Blood, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Quipt Home Medical | 1 | 0 | 3 | 2 | 3.00 |
| Global Cord Blood | 0 | 0 | 0 | 0 | 0.00 |
Quipt Home Medical currently has a consensus target price of $6.25, suggesting a potential upside of 106.95%. Given Quipt Home Medical’s stronger consensus rating and higher possible upside, equities analysts plainly believe Quipt Home Medical is more favorable than Global Cord Blood.
Insider and Institutional Ownership
42.9% of Quipt Home Medical shares are held by institutional investors. 4.2% of Quipt Home Medical shares are held by company insiders. Comparatively, 0.5% of Global Cord Blood shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Risk & Volatility
Quipt Home Medical has a beta of 0.56, meaning that its stock price is 44% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500.
Summary
Quipt Home Medical beats Global Cord Blood on 8 of the 15 factors compared between the two stocks.
About Quipt Home Medical
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
About Global Cord Blood
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.
